Fundraising FoxZosano Pharma
Fremont, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into Zosano Pharma
Sign up to see every warm intro you have to Zosano Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zosano Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Zosano Pharma was founded in 2012 by Peter Daddona.
CK
Christopher KruegerExecutive
Board
MJ
M. James BarrettBoard director
BS
Bruce SteelBoard director
KX
Kleanthis XanthopoulosBoard director
TW
Troy WilsonBoard director
JR
John RichardBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$26.4M disclosed across 4 of 5 rounds · 2014–2016
▶$7.5MraisedAug 2016 · 18 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedAug 2016 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bruce D. SteelDirector
- Kleanthis XanthopoulosDirector
- John WalkerDirector
- Haley LewisExecutive Officer
- Troy WilsonDirector
- Donald KellermanExecutive Officer
- Joseph P. HaganDirector
- Winnie TsoExecutive Officer
- Konstantinos AlatarisExecutive Officer, Director
- Eric ScharinExecutive Officer
- Georgia ErbezExecutive Officer
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- Sales commissions
- $527.5K
- Placement agents
- Roth Capital Partners, LLC, Guggenheim Securities, LLC
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$300KofferedJun 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$300KofferedJun 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter DaddonaExecutive Officer, Director
- Kleanthis XanthopoulosDirector
- Joseph HaganDirector
- Winnie TsoExecutive Officer
- Vikram LambaExecutive Officer, Director
- Troy WilsonDirector
- Bruce SteelDirector
- Laxmi PeriExecutive Officer
- M. James BarrettDirector
- Offering amount
- $300K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$15MraisedFeb 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedFeb 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Winnie TsoExecutive Officer
- M. James BarrettDirector
- Nandan OzaExecutive Officer
- Peter DaddonaExecutive Officer, Director
- Kleanthis XanthopoulosDirector
- Troy WilsonDirector
- Bruce SteelDirector
- Vikram LambaExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.3MraisedDec 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedDec 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- M. James BarrettDirector
- Nandan OzaExecutive Officer
- Winnie TsoExecutive Officer
- Bruce SteelDirector
- Vikram LambaExecutive Officer, Director
- Troy WilsonDirector
- Peter DaddonaExecutive Officer, Director
- Kleanthis XanthopoulosDirector
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2.5MraisedMar 2014 · 3 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedMar 2014 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vikram LambaExecutive Officer, Director
- Kleanthis XanthopoulosDirector
- John RichardDirector
- Bruce SteelDirector
- Nandan OzaExecutive Officer
- Christopher KruegerExecutive Officer
- Peter DaddonaExecutive Officer, Director
- M. James BarrettDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Zosano Pharma?
- Zosano Pharma was founded by Peter Daddona in 2012.
- Who are Zosano Pharma's investors?
- Zosano Pharma's investors include Aisling Capital.
- How much funding has Zosano Pharma raised?
- Zosano Pharma has disclosed $26.4M raised across 4 of its 5 known rounds.
- Where is Zosano Pharma headquartered?
- Zosano Pharma is headquartered in Fremont, US.